Anti-sCD40 (soluble) [T8P2G4*A6]
Invented by Ayham Alnabulsi from Vertebrate Antibodies Limited
Invented at Vertebrate Antibodies Limited
- Datasheet
- References (0)
- Inventor Info
Info
Catalogue Number | 152605 |
Applications | ELISA IHC WB |
Antigen/Gene or Protein Targets | CD40 Molecule, TNF Receptor Superfamily Member 5 (CD40 soluble form) |
Synonyms | CD40 Molecule; CD40L Receptor; TNFRSF5; CDW40; Bp50; Tumor Necrosis Factor Receptor Superfamily; Member; B Cell Surface Antigen CD40; CD40 Antigen; P50 |
Reactivity | Human |
Relevance | CD40 is a 48 kD type I glycoprotein and a member of the TNFR superfamily primarily expressed on B cells, macrophages, follicular dendritic cells, endothelial cells, fibroblasts, and at low levels on plasma cells. CD40 is also expressed on a wide range of tumor cells, including non-Hodgkin's and Hodgkin's lymphomas, myeloma and some carcinomas including nasopharynx, bladder, cervix, kidney and ovary.The binding of CD154 (CD40L) on TH cells to CD40 activates antigen presenting cells and induces a variety of downstream effects. |
Host | Mouse |
Immunogen | Ovalbumin-conjugated synthetic peptide RDPVCHPLGA (C-terminal sequence) |
Positive Control | IHC - formalin-fixed, paraffin-embedded hepatocellular carcinoma sections; WB - Jurkat cell lysates |
Subclass | IgG2b kappa |
Molecular Weight (kDa) | 22 |
Research Area | Cancer, Cell Signaling & Signal Transduction |
References
There are 0 reference entries for this reagent.
References: 0 entry
There is no reference for this reagent yet, feel free to use the button below to suggest one.
Add a reference
References: 0 entry
There is no reference for this reagent yet, feel free to use the button below to suggest one.
Add a reference